An Analysis from the ICGG Gaucher Registry: A Report of Gaucher Patients Affected by Reduced Doses of Imiglucerase

被引：0
|
作者：
Cole, Alexander [1 ]
Weinreb, Neal [2 ]
Rosenbloom, Barry [3 ]
Andersson, Hans [4 ]
Tripuraneni, Radhika [1 ]
Belmatoug, Nadia [5 ]
机构：
[1] Genzyme Corp, Cambridge, MA USA
[2] Univ Res Fdn Lysosomal Storage Disorders, Coral Springs, FL USA
[3] Tower Hematol Oncol Med Grp, Beverly Hills, CA USA
[4] Tulane Univ, New Orleans, LA 70118 USA
[5] Hop Beaujon, Paris, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
159
引用
收藏
页码：S69 / S69
页数：1
相关论文
共 50 条
  • [1] A preliminary analysis from the ICGG Gaucher registry: Short-term clinical outcomes in Gaucher patients affected by the shortage of imiglucerase
    Weinreb, Neal
    Rosenbloom, Barry
    Andersson, Hans
    Cole, Alexander
    Tripuraneni, Radhika
    Belmatoug, Nadia
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (02) : S45 - S45
  • [2] A Report from the International Collaborative Gaucher Group (ICGG) Gaucher Registry
    vom Dahl, Stephan
    Cole, J. Alexander
    Weinreb, Neal J.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S225 - S226
  • [3] A Report from the International Collaborative Gaucher Group (ICGG) Gaucher Registry
    Weinreb, Neal J.
    Dahl, Stephan Vom
    BLOOD, 2008, 112 (11) : 1215 - 1215
  • [4] Risk factors for fracture in imiglucerase-treated Gaucher disease type 1 patients in the ICGG Gaucher Registry
    Deegan, Patrick B.
    Batista, Julie
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S40 - S40
  • [5] Baseline characteristics of 32 patients with Gaucher disease who were treated with imiglucerase: South African data from the International Collaborative Gaucher Group (ICGG) Gaucher Registry
    Sevitz, H.
    Laher, F.
    Varughese, S. T.
    Nel, M.
    McMaster, A.
    Jacobso, B. F.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2022, 112 (01): : 31 - 36
  • [6] Phenotypic Spectrum of Hematological and Visceral Disease in Type 3 Gaucher Disease and Response to Imiglucerase Therapy: Preliminary Analysis from the ICGG Gaucher Registry
    Cole, J. Alexander
    Mistry, Pramod
    Kolodny, Edwin H.
    Tylki-Szymanska, Anna
    Belmatoug, Nadia
    Cabello, Juan F.
    Vellodi, Ashok
    Grabowski, Gregory
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 154 - 154
  • [7] Gaucher disease type 1 patients from the ICGG Gaucher Registry sustain initial clinical improvements during twenty years of imiglucerase treatment
    Weinreb, Neal J.
    Camelo, Jose Simon, Jr.
    Charrow, Joel
    McClain, Monica R.
    Mistry, Pramod
    Belmatoug, Nadia
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : 100 - 111
  • [8] Phenotypic Spectrum of Hematological and Visceral Disease in Type 3 Gaucher Disease and Response to Imiglucerase Therapy: Preliminary Analysis from the ICGG Gaucher Registry
    Misty, Pramod
    Kolodny, Edwin
    Tylki-Szymanska, Anna
    Belmatoug, Nadia
    Cabello, Juan
    Vellodi, Ashok
    Cole, J. Alexander
    Grabowski, Gregory
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S46 - S47
  • [9] Pregnancy outcomes in imiglucerase-treated patients with Gaucher disease: Real-world data from the International Collaborative Gaucher Group (ICGG) Gaucher Registry Pregnancy Sub-Registry
    Ficicioglu, Can
    Batista, Julie
    Carwile, Jenny L.
    Perichon, Maria
    Revel-Vilk, Shoshana
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [10] The incidence of Parkinsonism in patients with type 1 Gaucher disease: Data from the ICGG Gaucher Registry
    Rosenbloom, Barry
    Balwani, Manisha
    Bronstein, Jeff M.
    Kolodny, Edwin
    Sathe, Swati
    Gwosdow, Andrea R.
    Taylor, John S.
    Cole, J. Alexander
    Zimran, Ari
    Weinreb, Neal J.
    BLOOD CELLS MOLECULES AND DISEASES, 2011, 46 (01) : 95 - 102
12345